Literature DB >> 2919724

The role of phospholipase in host cell penetration by Toxoplasma gondii.

L D Saffer1, S A Long Krug, J D Schwartzman.   

Abstract

Phospholipase A2 (PLA2) plays an important pathogenic role in infections caused by several microorganisms and has been implicated in host cell invasion. The mechanism of host cell penetration by the intracellular protozoan Toxoplasma gondii involves several steps; we have investigated the role of PLA2 in cellular invasion by the tachyzoite stage of this parasite. We assayed T. gondii invasion of human fibroblast monolayers by measurement of the selective incorporation of 3H-uracil into growing intracellular parasites. Exogenous PLA2 from snake venom (Naja naja) increased the penetration of fibroblasts by T. gondii, while horse antiserum to Naja hannah venom inhibited penetration. An irreversible PLA2 inhibitor, p-bromophenacyl bromide, blocked penetration without metabolically disabling the parasite. When host fibroblasts were preincubated with this drug, penetration was not affected, supporting a role for parasite rather than host cell PLA2 in the penetration process. Another PLA2 inhibitor, nordihydroguaiaretic acid, also inhibited penetration. We assayed extracellular T. gondii tachyzoites, purified from host cell debris, for PLA2 activity by radiometric detection of fatty acid release from labeled Escherichia coli membranes. Sonically disrupted parasites contained a low level of calcium-dependent PLA2 with maximum activity at pH 8.5-9.0. These experiments suggest that a phospholipase is implicated in T. gondii host cell invasion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2919724     DOI: 10.4269/ajtmh.1989.40.145

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

Review 1.  Lytic cycle of Toxoplasma gondii.

Authors:  M W Black; J C Boothroyd
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

2.  Serine protease inhibitors block invasion of host cells by Toxoplasma gondii.

Authors:  V Conseil; M Soête; J F Dubremetz
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

3.  Laser scanning cytometer-based assays for measuring host cell attachment and invasion by the human pathogen Toxoplasma gondii.

Authors:  Jeffrey Mital; Janet Schwarz; Douglas J Taatjes; Gary E Ward
Journal:  Cytometry A       Date:  2006-01       Impact factor: 4.355

Review 4.  Potential role of phospholipases in virulence and fungal pathogenesis.

Authors:  M A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75.

Authors:  M Arrese; A Portela
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Phospholipase activities in clinical and environmental isolates of Acanthamoeba.

Authors:  Abdul Matin; Suk-Yul Jung
Journal:  Korean J Parasitol       Date:  2011-03-18       Impact factor: 1.341

7.  A Cryptosporidium parvum genomic region encoding hemolytic activity.

Authors:  M I Steele; T L Kuhls; K Nida; C S Meka; I M Halabi; D A Mosier; W Elliott; D L Crawford; R A Greenfield
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  The role of Cryptosporidium parvum-derived phospholipase in intestinal epithelial cell invasion.

Authors:  R C G Pollok; V McDonald; P Kelly; M J G Farthing
Journal:  Parasitol Res       Date:  2003-02-26       Impact factor: 2.289

9.  4-Bromophenacyl bromide specifically inhibits rhoptry secretion during Toxoplasma invasion.

Authors:  Sandeep Ravindran; Melissa B Lodoen; Steven H L Verhelst; Matthew Bogyo; John C Boothroyd
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

10.  Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells.

Authors:  Romina S Goldszmid; Isabelle Coppens; Avital Lev; Pat Caspar; Ira Mellman; Alan Sher
Journal:  J Exp Med       Date:  2009-01-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.